Intelligence · Clinical Pipeline
AstraZeneca Pipeline
All ClinicalTrials.gov programs at AstraZeneca — phase, modality, and trial IDs.
- Programs
- 11
Quick answer
AstraZeneca has 11 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
AZD0449
AstraZeneca
Asthma
1 trial -
AZD0530
AstraZeneca
Solid Tumor
1 trial -
AZD3514
AstraZeneca
Prostate Cancer
1 trial -
AZD6244
AstraZeneca
Neoplasms,
1 trial -
AZD7762
AstraZeneca
Cancer
1 trial -
Benralizumab
AstraZeneca
Healthy Subjects
1 trial -
Capivasertib
AstraZeneca
Advanced Solid Tumours
1 trial -
Ceralasertib
AstraZeneca
Advanced Solid Malignancies
1 trial -
Cisplatin
AstraZeneca
Inoperable Locally Advanced or Metastatic Biliary Tract Cancer
1 trial -
Drug-AZD8931
AstraZeneca
Breast Neoplasm
1 trial -
Sodium Zirconium Cyclosilicate (ZS)
AstraZeneca
Hyperkalemia
1 trial
Frequently asked questions
How many pipeline programs does AstraZeneca have?
11 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs